Objective
To investigate drug usage and costs of ischemic stroke inpatients in Karamay Central Hospital in 2014 and to provide evidence and reference for evidence-based pharmacy study of single disease in circulation system.
Methods
The information of drug use and expenditure of ischemic stroke inpatients were collected from the hspital information system (HIS). We analyzed the data including frequency, proportion and cumulative proportion by Excel 2007 software.
Results
We included 522 ischemic stroke inpatients in Karamay Central Hospital in 2014, the average age was 67.58±13.27 years old. Forty three kinds of drugs were used for ischemic stroke therapy. The total expenditure of drugs was 10.94 million and 1 807.99 yuan per person. The most used drugs were for symptomatic treatment which included 18 kinds of drugs. The using frequency of aspirin, edaravone, oxircetan were the highest. The secondary prevention medicines included 23 kinds of drugs. The anti-hypertensive, lipid-lowering and hypoglycemic agents were prescribed mostly. Traditional Chinese medicines were prescribed 234 times, and the injection Ligustrazine with glucose was the most used drug.
Conclusion
The mainly drugs for treatment of ischemia stroke inpatients in Karamay Central Hospital in 2014 are aspirin, edaravone and oxircetan; while the expenditure of clopidogrel and oxiracetam were the highest.
Citation：
WANG Guotuan, YU Jiajie, WU Min, LI Youping, ZHANG Weidong, XU Ting, KUANG Liping, LU Jing, FANG Yiqing, SUN Xin, SU Guanyue. Drug usage and costs of inpatients with ischemic stroke in Karamay Central Hospital in 2014. Chinese Journal of Evidence-Based Medicine, 2017, 17(8): 895-898. doi: 10.7507/1672-2531.201610065
Copy
Copyright © the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved
| 1. |
赵澎, 胡微, 乌尤图, 等. 神经保护剂的应用与评价. 中华神经外科疾病研究杂志, 2015, 14(2): 188-189.
|
| 2. |
Adams HP Jr, del Zoppo G, José B, et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of adults with ischemic stroke. Stroke, 2015, 46(11): 3020-3039.
|
| 3. |
中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南 2014 版. 中华神经科杂志, 2015, 48(4): 246-257.
|
| 4. |
Walter NK, Bruce O, Henry RB, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke, 2014, 45(7): 2160-2236.
|
| 5. |
Venketasubramanian N, Pwee KH, Chen CP, et al. Singapore ministry of health clinical practice guidelines on stroke and transient ischemic attacks. Int J Stroke, 2011, 6(3): 251-258.
|
| 6. |
Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke. Stroke, 2007, 38(5): 1655-1711.
|
| 7. |
杜官林, 荣阳, 贾韵楠. 脑梗死的二级预防疾病防控. 疾病防控, 2009, 16(7): 122-123.
|
| 8. |
中华医学会神经病学分会脑血管病学组缺血性脑卒中二级预防指南撰写组. 中国缺血性脑卒中和短暂性脑缺血发作二级预防指南. 中国临床医生, 2011, 39(11): 68-74.
|
- 1. 赵澎, 胡微, 乌尤图, 等. 神经保护剂的应用与评价. 中华神经外科疾病研究杂志, 2015, 14(2): 188-189.
- 2. Adams HP Jr, del Zoppo G, José B, et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of adults with ischemic stroke. Stroke, 2015, 46(11): 3020-3039.
- 3. 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南 2014 版. 中华神经科杂志, 2015, 48(4): 246-257.
- 4. Walter NK, Bruce O, Henry RB, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke, 2014, 45(7): 2160-2236.
- 5. Venketasubramanian N, Pwee KH, Chen CP, et al. Singapore ministry of health clinical practice guidelines on stroke and transient ischemic attacks. Int J Stroke, 2011, 6(3): 251-258.
- 6. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke. Stroke, 2007, 38(5): 1655-1711.
- 7. 杜官林, 荣阳, 贾韵楠. 脑梗死的二级预防疾病防控. 疾病防控, 2009, 16(7): 122-123.
- 8. 中华医学会神经病学分会脑血管病学组缺血性脑卒中二级预防指南撰写组. 中国缺血性脑卒中和短暂性脑缺血发作二级预防指南. 中国临床医生, 2011, 39(11): 68-74.
